RIFABUTIN

RIFABUTIN was reported 2755 times

RIFABUTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADENOVIRUS TEST NEGATIVE 1 1.0000
1 RETICULOCYTE HAEMOGLOBIN DECREASED 2 0.2857
2 AIDS CHOLANGIOPATHY 2 0.1667
3 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 34 0.1538
4 HIV WASTING SYNDROME 5 0.1389
5 ATYPICAL MYCOBACTERIAL LYMPHADENITIS 5 0.1163
6 BRONCHIAL ARTERY EMBOLISATION 2 0.1053
7 MINIMUM INHIBITORY CONCENTRATION INCREASED 2 0.1000
8 ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION 6 0.0833
9 BILATERAL TONIC CLONIC SEIZURE 1 0.0769
10 GYNAECOLOGICAL CHLAMYDIA INFECTION 4 0.0755
11 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 25 0.0746
12 INCOMPLETE SPINAL FUSION 2 0.0714
13 MYCOBACTERIUM HAEMOPHILUM INFECTION 17 0.0594
14 ACID FAST BACILLI INFECTION 9 0.0559
15 MYCOBACTERIUM AVIUM COMPLEX INFECTION 150 0.0558
16 AIDS ENCEPHALOPATHY 3 0.0517
17 NECROTISING GRANULOMATOUS LYMPHADENITIS 2 0.0465
18 ATYPICAL MYCOBACTERIAL PNEUMONIA 6 0.0432
19 ANTICOAGULATION DRUG LEVEL DECREASED 5 0.0413
20 ATYPICAL MYCOBACTERIUM TEST POSITIVE 4 0.0412
21 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 11 0.0406
22 IMMUNE RECOVERY UVEITIS 2 0.0345
23 PULMONARY HILUM MASS 6 0.0319
24 TUBERCULOID LEPROSY 2 0.0308
25 AORTICOPULMONARY SEPTAL DEFECT 1 0.0303
26 COLOUR VISION TESTS ABNORMAL 2 0.0303
27 RHODOCOCCUS INFECTION 5 0.0301
28 MYCOBACTERIAL INFECTION 50 0.0290
29 ATYPICAL MYCOBACTERIAL INFECTION 41 0.0290
30 ANTI-HBC ANTIBODY POSITIVE 1 0.0286
31 LEISHMANIASIS 8 0.0276
32 FEMORAL ARTERY ANEURYSM 3 0.0273
33 NECROTISING HERPETIC RETINOPATHY 2 0.0270
34 IMMUNE RECONSTITUTION SYNDROME 31 0.0240
35 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 119 0.0239
36 MESENTERIC PANNICULITIS 7 0.0234
37 TUBERCULOSIS OF GENITOURINARY SYSTEM 2 0.0220
38 MYCOBACTERIUM MARINUM INFECTION 7 0.0215
39 KIDNEY RUPTURE 4 0.0215
40 MULTIPLE DRUG HYPERSENSITIVITY 2 0.0208
41 HYPOPYON 17 0.0205
42 LEUKOERYTHROBLASTOSIS 2 0.0200
43 MYCOBACTERIUM TEST POSITIVE 4 0.0194
44 BASOPHIL COUNT ABNORMAL 1 0.0185
45 DOSING ERROR 3 0.0179
46 INTESTINAL MUCOSAL HYPERTROPHY 3 0.0164
47 PERIPORTAL OEDEMA 2 0.0160
48 MEDIASTINAL MASS 6 0.0157
49 MYCOBACTERIUM ABSCESSUS INFECTION 11 0.0154
50 CHYLOTHORAX 10 0.0139
51 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 5 0.0138
52 BRUCELLOSIS 2 0.0132
53 OTOTOXICITY 24 0.0130
54 SALMONELLA SEPSIS 3 0.0125
55 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 15 0.0125
56 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 11 0.0124
57 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 5 0.0123
58 CYTOMEGALOVIRUS CHORIORETINITIS 24 0.0123
59 CEREBRAL CONGESTION 2 0.0119
60 CEREBRAL TOXOPLASMOSIS 11 0.0118
61 INTESTINAL TUBERCULOSIS 2 0.0115
62 MICROSPORIDIA INFECTION 4 0.0114
63 CEREBRAL CALCIFICATION 3 0.0112
64 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 2 0.0110
65 CUTANEOUS TUBERCULOSIS 2 0.0110
66 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY 1 0.0109
67 MYCOBACTERIUM CHELONAE INFECTION 8 0.0108
68 CORNEAL DEPOSITS 8 0.0108
69 REPETITIVE SPEECH 6 0.0107
70 BRONCHOPLEURAL FISTULA 4 0.0106
71 PULMONARY CAVITATION 9 0.0103
72 HILAR LYMPHADENOPATHY 9 0.0102
73 KAPOSI'S SARCOMA 5 0.0100
74 HYPOCHROMASIA 2 0.0100
75 PNEUMOCYSTIS CARINII PNEUMONIA 2 0.0099
76 GASTROENTERITIS CRYPTOSPORIDIAL 2 0.0099
77 CRYSTAL ARTHROPATHY 2 0.0095
78 MICROTIA 3 0.0095
79 TUBERCULOSIS GASTROINTESTINAL 3 0.0094
80 DISSEMINATED TUBERCULOSIS 24 0.0093
81 TOXIC OPTIC NEUROPATHY 4 0.0092
82 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 6 0.0090
83 CAROTID ARTERY ANEURYSM 3 0.0088
84 ABDOMINAL FAT APRON 1 0.0085
85 KIDNEY MALFORMATION 3 0.0085
86 PLASMABLASTIC LYMPHOMA 3 0.0084
87 IRIDOCYCLITIS 26 0.0082
88 ABDOMINAL LYMPHADENOPATHY 7 0.0081
89 LYMPH NODE TUBERCULOSIS 6 0.0081
90 MICROCYTOSIS 2 0.0081
91 DEAFNESS NEUROSENSORY 26 0.0079
92 CHEST WALL MASS 2 0.0077
93 DEPOSIT EYE 2 0.0075
94 POIKILOCYTOSIS 2 0.0072
95 THYROID CANCER METASTATIC 2 0.0071
96 PERITONEAL TUBERCULOSIS 3 0.0068
97 BACTERIAL ABDOMINAL INFECTION 1 0.0068
98 ALVEOLAR PROTEINOSIS 4 0.0068
99 POLYCHROMASIA 2 0.0067
100 LYMPHADENITIS 16 0.0066
101 CHRONIC HEPATITIS B 2 0.0063
102 INTRA-ABDOMINAL HAEMORRHAGE 15 0.0063
103 DRUG RESISTANCE 161 0.0063
104 ASPERGILLOMA 2 0.0063
105 OPTIC NEUROPATHY 13 0.0061
106 CRYPTOCOCCOSIS 10 0.0061
107 MULTIPLE-DRUG RESISTANCE 19 0.0061
108 DEAFNESS BILATERAL 10 0.0059
109 LYMPHADENOPATHY MEDIASTINAL 11 0.0057
110 ANION GAP DECREASED 2 0.0057
111 DRUG LEVEL ABNORMAL 3 0.0056
112 GLOMERULONEPHRITIS PROLIFERATIVE 2 0.0055
113 ABSCESS BACTERIAL 2 0.0055
114 OCULAR TOXICITY 6 0.0054
115 CYTOMEGALOVIRUS OESOPHAGITIS 2 0.0054
116 IDIOSYNCRATIC DRUG REACTION 5 0.0051
117 EXTRADURAL ABSCESS 4 0.0051
118 SPUTUM RETENTION 5 0.0050
119 GROWTH HORMONE DEFICIENCY 2 0.0050
120 BLOOD HIV RNA INCREASED 9 0.0050
121 SPUTUM CULTURE POSITIVE 4 0.0049
122 OPEN ANGLE GLAUCOMA 3 0.0049
123 OESOPHAGEAL ATRESIA 3 0.0048
124 TRANSFERRIN SATURATION DECREASED 2 0.0047
125 PARADOXICAL DRUG REACTION 17 0.0046
126 BRONCHIECTASIS 31 0.0046
127 JOINT DESTRUCTION 7 0.0045
128 PATHOGEN RESISTANCE 41 0.0045
129 UVEITIS 61 0.0045
130 HEPATIC ENZYME DECREASED 2 0.0045
131 HYPERTRANSAMINASAEMIA 31 0.0045
132 URINARY TRACT INFECTION ENTEROCOCCAL 4 0.0043
133 DRUG LEVEL DECREASED 43 0.0042
134 CRANIAL NERVE PARALYSIS 2 0.0042
135 HEPATITIS TOXIC 11 0.0042
136 PULMONARY TUBERCULOSIS 18 0.0042
137 VASCULITIS NECROTISING 3 0.0042
138 CHRONIC RESPIRATORY FAILURE 5 0.0041
139 LYMPHADENECTOMY 4 0.0041
140 NOSOCOMIAL INFECTION 9 0.0041
141 ENCEPHALITIS HERPES 2 0.0040
142 INFECTIVE ANEURYSM 2 0.0040
143 PERSECUTORY DELUSION 10 0.0040
144 BETA 2 MICROGLOBULIN INCREASED 1 0.0038
145 INFUSION SITE VESICLES 2 0.0038
146 VITRITIS 7 0.0038
147 DYSCHROMATOPSIA 3 0.0036
148 MENINGITIS TUBERCULOUS 2 0.0036
149 HEPATITIS CHOLESTATIC 21 0.0035
150 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 1 0.0034
151 PROCALCITONIN INCREASED 4 0.0034
152 VARICELLA ZOSTER VIRUS INFECTION 7 0.0034
153 ABSCESS LIMB 14 0.0033
154 APOPTOSIS 1 0.0032
155 BLOOD BILIRUBIN DECREASED 2 0.0032
156 SPUTUM INCREASED 7 0.0032
157 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 82 0.0032
158 GRANULOMA 11 0.0032
159 INCREASED VISCOSITY OF BRONCHIAL SECRETION 2 0.0031
160 ILEOSTOMY 8 0.0031
161 BRONCHOPULMONARY ASPERGILLOSIS 24 0.0031
162 CROSS SENSITIVITY REACTION 3 0.0031
163 DUST ALLERGY 3 0.0031
164 HEMIANOPIA 3 0.0030
165 SPUTUM ABNORMAL 2 0.0030
166 ACUTE HEPATITIS B 1 0.0030
167 TRANSPLANT REJECTION 23 0.0029
168 RETROPERITONEAL HAEMORRHAGE 7 0.0028
169 JARISCH-HERXHEIMER REACTION 2 0.0028
170 MENINGITIS BACTERIAL 4 0.0028
171 HODGKIN'S DISEASE 2 0.0028
172 BLOOD FOLATE DECREASED 2 0.0028
173 FOOT AMPUTATION 4 0.0027
174 GASTRITIS HAEMORRHAGIC 4 0.0027
175 TENDON DISCOMFORT 2 0.0026
176 CHLAMYDIAL INFECTION 2 0.0026
177 BASOPHIL COUNT INCREASED 2 0.0026
178 PULMONARY GRANULOMA 3 0.0026
179 INFECTION REACTIVATION 3 0.0026
180 ASPERGILLUS INFECTION 17 0.0026
181 POLYDACTYLY 3 0.0026
182 CONVERSION DISORDER 5 0.0026
183 PNEUMONIA INFLUENZAL 3 0.0025
184 OESOPHAGEAL CANDIDIASIS 10 0.0025
185 SUBCUTANEOUS ABSCESS 12 0.0025
186 ENTEROCOCCAL SEPSIS 2 0.0025
187 BLOOD ELECTROLYTES ABNORMAL 3 0.0024
188 ANAEMIA HAEMOLYTIC AUTOIMMUNE 2 0.0024
189 ABDOMINAL CAVITY DRAINAGE 1 0.0024
190 MIXED LIVER INJURY 7 0.0023
191 TONGUE PRURITUS 2 0.0023
192 FIXED ERUPTION 4 0.0023
193 NEPHROPATHY TOXIC 26 0.0023
194 OCULAR ICTERUS 10 0.0023
195 ELECTROCARDIOGRAM T WAVE INVERSION 5 0.0023
196 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20 0.0023
197 HEPATOTOXICITY 50 0.0022
198 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
199 THERAPEUTIC PRODUCT CROSS-REACTIVITY 2 0.0022
200 LIVER TRANSPLANT REJECTION 4 0.0022
201 ANAEMIA OF CHRONIC DISEASE 2 0.0022
202 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
203 CORNEAL OPACITY 3 0.0022
204 ACUTE HEPATIC FAILURE 30 0.0022
205 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
206 LICHEN PLANUS 5 0.0022
207 ARTHRITIS INFECTIVE 10 0.0022
208 H1N1 INFLUENZA 3 0.0021
209 BASEDOW'S DISEASE 1 0.0021
210 INTERVERTEBRAL DISCITIS 4 0.0021
211 PYELOCALIECTASIS 2 0.0021
212 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
213 RENAL TRANSPLANT FAILURE 2 0.0020
214 HYPOCHROMIC ANAEMIA 2 0.0020
215 CALCULUS URINARY 3 0.0019
216 ACQUIRED IMMUNODEFICIENCY SYNDROME 1 0.0019
217 LYMPHOPENIA 27 0.0019
218 FUNGAEMIA 3 0.0019
219 LUNG ABSCESS 4 0.0019
220 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
221 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 2 0.0018
222 RASH MORBILLIFORM 5 0.0018
223 PSEUDOMEMBRANOUS COLITIS 4 0.0018
224 SUSPECTED OFF LABEL USE 8 0.0018
225 BLOOD FIBRINOGEN DECREASED 2 0.0018
226 CACHEXIA 9 0.0017
227 PULMONARY MASS 26 0.0017
228 ENTEROCOLITIS 10 0.0017
229 SYSTEMIC MYCOSIS 2 0.0017
230 LIP ULCERATION 2 0.0017
231 FANCONI SYNDROME ACQUIRED 3 0.0017
232 DRUG INTERACTION 270 0.0017
233 VIROLOGIC FAILURE 9 0.0017
234 HIV INFECTION 5 0.0017
235 MONOCYTE COUNT DECREASED 2 0.0016
236 EOSINOPHILIC PNEUMONIA 5 0.0016
237 ARTERITIS 1 0.0016
238 HYPOPROTEINAEMIA 3 0.0016
239 ANION GAP 1 0.0016
240 DEAFNESS 41 0.0016
241 HEPATIC INFECTION 2 0.0016
242 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
243 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
244 ANISOCYTOSIS 1 0.0015
245 ELECTROCARDIOGRAM QT PROLONGED 54 0.0015
246 NEPHRITIS 5 0.0015
247 ABSCESS NECK 1 0.0015
248 CARBON DIOXIDE INCREASED 2 0.0015
249 ARTHRITIS BACTERIAL 6 0.0015
250 HYPERURICAEMIA 6 0.0015
251 ANGULAR CHEILITIS 1 0.0014
252 HYPOSPADIAS 3 0.0014
253 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
254 RENAL TUBULAR DISORDER 4 0.0014
255 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
256 ENTERITIS 9 0.0014
257 CD4 LYMPHOCYTES DECREASED 3 0.0014
258 VITREOUS DETACHMENT 3 0.0014
259 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
260 RENAL TUBULAR ACIDOSIS 3 0.0014
261 HENOCH-SCHONLEIN PURPURA 3 0.0014
262 DYSPHEMIA 6 0.0014
263 NORMOCYTIC ANAEMIA 2 0.0014
264 IMMUNOSUPPRESSION 12 0.0014
265 VIRAL MUTATION IDENTIFIED 5 0.0014
266 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
267 DRUG INTOLERANCE 129 0.0013
268 OPTIC NEURITIS 12 0.0013
269 PNEUMONIA PSEUDOMONAL 2 0.0013
270 LEUKOPENIA 65 0.0013
271 MEAN CELL VOLUME DECREASED 2 0.0013
272 METHAEMOGLOBINAEMIA 3 0.0013
273 PULMONARY FUNCTION TEST ABNORMAL 2 0.0013
274 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 3 0.0013
275 EOSINOPHIL COUNT DECREASED 3 0.0013
276 HEPATIC CYTOLYSIS 16 0.0013
277 PANCYTOPENIA 70 0.0013
278 MALNUTRITION 14 0.0013
279 CUSHINGOID 4 0.0012
280 OPTIC ATROPHY 2 0.0012
281 CYTOPENIA 15 0.0012
282 RENAL TUBULAR NECROSIS 12 0.0012
283 HEPATOMEGALY 12 0.0012
284 OXYGEN THERAPY 2 0.0012
285 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
286 POTENTIATING DRUG INTERACTION 4 0.0012
287 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
288 BRAIN ABSCESS 3 0.0012
289 HAEMOPTYSIS 33 0.0012
290 HEPATOSPLENOMEGALY 3 0.0012
291 LUNG OPACITY 3 0.0011
292 ABDOMINAL SEPSIS 1 0.0011
293 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
294 HYPERCALCAEMIA 14 0.0011
295 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
296 ANOGENITAL WARTS 1 0.0011
297 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
298 HYDROCEPHALUS 6 0.0011
299 CHOLESTASIS 21 0.0011
300 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
301 IMMUNE THROMBOCYTOPENIA 5 0.0011
302 OESOPHAGEAL SPASM 2 0.0011
303 BIOPSY 1 0.0011
304 BLOOD BICARBONATE DECREASED 2 0.0011
305 OESOPHAGEAL ULCER 4 0.0010
306 HAEMOLYSIS 8 0.0010
307 ENTEROCOCCAL INFECTION 5 0.0010
308 ADENOVIRUS INFECTION 3 0.0010
309 RASH VESICULAR 5 0.0010
310 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
311 CONCOMITANT DISEASE PROGRESSION 2 0.0010
312 HEPATITIS FULMINANT 3 0.0010
313 GENE MUTATION 2 0.0010
314 EMPYEMA 2 0.0010
315 BRAIN HERNIATION 3 0.0010
316 ATYPICAL PNEUMONIA 3 0.0010
317 BLOOD CULTURE POSITIVE 3 0.0010
318 TREATMENT FAILURE 83 0.0010
319 DERMATITIS EXFOLIATIVE 5 0.0010
320 HYPERCAPNIA 3 0.0010
321 PNEUMONIA BACTERIAL 9 0.0010
322 PANIC REACTION 7 0.0010
323 VISUAL FIELD DEFECT 7 0.0010
324 DRUG LEVEL INCREASED 16 0.0010
325 FAILURE TO THRIVE 5 0.0010
326 CONGESTIVE CARDIOMYOPATHY 4 0.0010
327 DRUG-INDUCED LIVER INJURY 30 0.0010
328 RASH MACULO-PAPULAR 21 0.0009
329 HYPERPHOSPHATAEMIA 2 0.0009
330 LYMPHOCYTOSIS 2 0.0009
331 ABSCESS INTESTINAL 2 0.0009
332 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
333 ADRENAL INSUFFICIENCY 11 0.0009
334 NECROSIS 5 0.0009
335 BACTERIAL TEST POSITIVE 2 0.0009
336 TORSADE DE POINTES 7 0.0009
337 BONE MARROW FAILURE 18 0.0009
338 NEUTROPENIA 120 0.0009
339 EAR DISCOMFORT 9 0.0009
340 HYPERBILIRUBINAEMIA 9 0.0009
341 ACUTE PRERENAL FAILURE 1 0.0009
342 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 7 0.0008
343 DRUG ERUPTION 15 0.0008
344 LONG QT SYNDROME 2 0.0008
345 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
346 PANNICULITIS 2 0.0008
347 FOOD INTOLERANCE 3 0.0008
348 EOSINOPHILIA 14 0.0008
349 CHROMATURIA 18 0.0008
350 PLATELET DISORDER 2 0.0008
351 KLEBSIELLA INFECTION 4 0.0008
352 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
353 ANOREXIA 10 0.0008
354 BLOOD CHLORIDE DECREASED 2 0.0008
355 OSTEOMYELITIS 14 0.0008
356 VIRAL LOAD INCREASED 3 0.0008
357 HEPATITIS ACUTE 5 0.0008
358 RETINAL DISORDER 2 0.0008
359 HYPERSENSITIVITY VASCULITIS 2 0.0008
360 PNEUMONIA FUNGAL 3 0.0008
361 CARDIAC FAILURE ACUTE 5 0.0007
362 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
363 CANDIDIASIS 3 0.0007
364 WHITE BLOOD CELL DISORDER 2 0.0007
365 STEATORRHOEA 2 0.0007
366 HYPERLACTACIDAEMIA 2 0.0007
367 ORGAN FAILURE 3 0.0007
368 SPUTUM DISCOLOURED 7 0.0007
369 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
370 ACCIDENTAL POISONING 1 0.0007
371 SECRETION DISCHARGE 9 0.0007
372 LUNG CONSOLIDATION 2 0.0007
373 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 39 0.0007
374 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
375 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
376 AUDITORY DISORDER 1 0.0007
377 OESOPHAGEAL STENOSIS 2 0.0007
378 RESPIRATORY SYMPTOM 2 0.0007
379 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
380 LIP PAIN 2 0.0007
381 HEPATIC FUNCTION ABNORMAL 26 0.0007
382 ORAL CANDIDIASIS 9 0.0007
383 SARS-COV-2 TEST POSITIVE 9 0.0007
384 ABDOMINAL ABSCESS 3 0.0007
385 LYMPHADENOPATHY 24 0.0007
386 HYPOPHOSPHATAEMIA 5 0.0007
387 CREPITATIONS 2 0.0007
388 ODYNOPHAGIA 4 0.0007
389 HAEMOLYTIC ANAEMIA 6 0.0007
390 HYPERLIPIDAEMIA 8 0.0007
391 HEPATITIS 17 0.0007
392 BONE MARROW DISORDER 2 0.0007
393 LUPUS-LIKE SYNDROME 6 0.0007
394 ASTIGMATISM 1 0.0007
395 EMERGENCY CARE 2 0.0007
396 ASCITES 19 0.0006
397 PERSONALITY CHANGE 6 0.0006
398 BLOOD CREATININE DECREASED 2 0.0006
399 THROMBOCYTOPENIA 71 0.0006
400 PNEUMONIA VIRAL 2 0.0006
401 KIDNEY TRANSPLANT REJECTION 3 0.0006
402 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
403 HERPES SIMPLEX 4 0.0006
404 VITREOUS FLOATERS 6 0.0006
405 TINNITUS 28 0.0006
406 PANCREATIC DISORDER 3 0.0006
407 HYPERVOLAEMIA 3 0.0006
408 EOSINOPHIL COUNT INCREASED 5 0.0006
409 LYME DISEASE 2 0.0006
410 MENINGITIS 4 0.0006
411 SPLENOMEGALY 7 0.0006
412 EMPHYSEMA 6 0.0006
413 NIGHT SWEATS 19 0.0006
414 BACTERIAL INFECTION 11 0.0006
415 DEVICE RELATED INFECTION 9 0.0006
416 TRANSAMINASES INCREASED 13 0.0006
417 AMYLOIDOSIS 1 0.0006
418 BLOOD CREATININE ABNORMAL 2 0.0006
419 DEPRESSION SUICIDAL 2 0.0006
420 PETECHIAE 6 0.0006
421 MALABSORPTION 3 0.0006
422 ACUTE RESPIRATORY FAILURE 11 0.0006
423 RIGHT VENTRICULAR FAILURE 4 0.0006
424 BLOOD LACTIC ACID INCREASED 3 0.0006
425 SERUM FERRITIN INCREASED 3 0.0006
426 RENAL FAILURE ACUTE 24 0.0006
427 PURPURA 5 0.0006
428 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
429 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
430 BONE LESION 2 0.0006
431 CUTANEOUS VASCULITIS 2 0.0005
432 PHOTOSENSITIVITY REACTION 9 0.0005
433 INTESTINAL ISCHAEMIA 3 0.0005
434 PRODUCTIVE COUGH 26 0.0005
435 CYSTIC FIBROSIS 3 0.0005
436 IRON DEFICIENCY ANAEMIA 5 0.0005
437 HIATUS HERNIA 7 0.0005
438 CARDIAC DYSFUNCTION 2 0.0005
439 VENTRICULAR SEPTAL DEFECT 3 0.0005
440 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
441 OESOPHAGEAL DISORDER 2 0.0005
442 SINUS CONGESTION 7 0.0005
443 LYMPHOMA 8 0.0005
444 NEUROPATHY PERIPHERAL 49 0.0005
445 LUNG DISORDER 25 0.0005
446 BACTERAEMIA 6 0.0005
447 DISEASE RECURRENCE 24 0.0005
448 BLOOD ALBUMIN DECREASED 4 0.0005
449 ANORECTAL DISORDER 1 0.0005
450 RENAL IMPAIRMENT 42 0.0005
451 MYELOSUPPRESSION 18 0.0005
452 HEPATITIS B 3 0.0005
453 ACUTE KIDNEY INJURY 76 0.0005
454 BRONCHOSPASM 7 0.0005
455 HICCUPS 4 0.0005
456 HELICOBACTER INFECTION 5 0.0005
457 JAUNDICE 13 0.0005
458 ILEUS 6 0.0005
459 HALLUCINATION, VISUAL 10 0.0005
460 PYREXIA 163 0.0005
461 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
462 ANAEMIA MACROCYTIC 1 0.0005
463 PSEUDOMONAS INFECTION 4 0.0005
464 LIVER FUNCTION TEST INCREASED 10 0.0005
465 ECONOMIC PROBLEM 7 0.0005
466 DELIRIUM 16 0.0005
467 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
468 HYPERKALAEMIA 16 0.0005
469 MELANOCYTIC NAEVUS 2 0.0005
470 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
471 THERAPY INTERRUPTED 32 0.0004
472 SKIN INFECTION 5 0.0004
473 HEPATIC ENZYME INCREASED 30 0.0004
474 PRODUCT USE IN UNAPPROVED INDICATION 109 0.0004
475 ENCEPHALITIS 3 0.0004
476 AGRANULOCYTOSIS 8 0.0004
477 APHONIA 6 0.0004
478 GASTRITIS EROSIVE 2 0.0004
479 HEPATIC ENCEPHALOPATHY 4 0.0004
480 BILIRUBIN CONJUGATED INCREASED 1 0.0004
481 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
482 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
483 TREATMENT NONCOMPLIANCE 23 0.0004
484 ANHEDONIA 11 0.0004
485 HYPOVOLAEMIC SHOCK 2 0.0004
486 RASH PUSTULAR 3 0.0004
487 PHARYNGEAL SWELLING 4 0.0004
488 STAPHYLOCOCCAL SEPSIS 2 0.0004
489 STEVENS-JOHNSON SYNDROME 9 0.0004
490 ACUTE PSYCHOSIS 1 0.0004
491 GASTROINTESTINAL DISORDER 36 0.0004
492 ANEURYSM 2 0.0004
493 SKIN LESION 11 0.0004
494 PANCREATITIS ACUTE 9 0.0004
495 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
496 DISEASE PROGRESSION 47 0.0004
497 TENDON PAIN 3 0.0004
498 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
499 APPENDICITIS PERFORATED 1 0.0004
500 ACIDOSIS 3 0.0004
501 NEUTROPHIL COUNT INCREASED 4 0.0004
502 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
503 APHTHOUS ULCER 3 0.0004
504 SKIN NECROSIS 2 0.0004
505 PELVIC FRACTURE 3 0.0004
506 TENDERNESS 4 0.0004
507 GASTRITIS 10 0.0004
508 HALLUCINATION, AUDITORY 6 0.0004
509 TRICUSPID VALVE INCOMPETENCE 3 0.0004
510 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
511 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
512 ABSCESS 6 0.0004
513 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
514 ABDOMINAL MASS 1 0.0004
515 BLOOD CREATININE INCREASED 24 0.0004
516 PRODUCT PRESCRIBING ISSUE 8 0.0004
517 OESOPHAGITIS 4 0.0004
518 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
519 VENTRICULAR FIBRILLATION 4 0.0004
520 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
521 STREPTOCOCCAL INFECTION 2 0.0004
522 INTRACRANIAL PRESSURE INCREASED 2 0.0004
523 ATRIAL SEPTAL DEFECT 3 0.0004
524 HAEMODIALYSIS 3 0.0004
525 SENSATION OF FOREIGN BODY 3 0.0004
526 TOXICITY TO VARIOUS AGENTS 60 0.0004
527 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
528 REBOUND EFFECT 4 0.0004
529 SEASONAL ALLERGY 5 0.0004
530 HEPATOCELLULAR INJURY 5 0.0004
531 GRANULOCYTOPENIA 2 0.0004
532 DYSPNOEA EXERTIONAL 13 0.0003
533 SEPTIC SHOCK 15 0.0003
534 RESPIRATORY FAILURE 25 0.0003
535 ABORTION 1 0.0003
536 HYPOVOLAEMIA 2 0.0003
537 LUNG INFILTRATION 3 0.0003
538 URINARY INCONTINENCE 10 0.0003
539 SYMPTOM RECURRENCE 2 0.0003
540 THERAPY NON-RESPONDER 15 0.0003
541 ENDOPHTHALMITIS 2 0.0003
542 LEUKOCYTOSIS 6 0.0003
543 INSURANCE ISSUE 5 0.0003
544 RESPIRATORY DISTRESS 9 0.0003
545 LIVER INJURY 8 0.0003
546 GRAND MAL CONVULSION 3 0.0003
547 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
548 MENTAL STATUS CHANGES 9 0.0003
549 TENDONITIS 5 0.0003
550 CHOLANGITIS 2 0.0003
551 ERYTHEMA MULTIFORME 3 0.0003
552 NEPHROPATHY 3 0.0003
553 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
554 CYANOSIS 5 0.0003
555 RENAL FAILURE 42 0.0003
556 MUSCLE ATROPHY 4 0.0003
557 PNEUMOTHORAX 5 0.0003
558 ANAEMIA 60 0.0003
559 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
560 PLEURAL EFFUSION 19 0.0003
561 INCOHERENT 2 0.0003
562 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
563 BACTERIAL SEPSIS 1 0.0003
564 TENDON DISORDER 2 0.0003
565 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
566 NODULE 4 0.0003
567 HYPOGAMMAGLOBULINAEMIA 2 0.0003
568 APPETITE DISORDER 2 0.0003
569 WEIGHT DECREASED 84 0.0003
570 CYTOMEGALOVIRUS INFECTION 5 0.0003
571 SKIN MASS 2 0.0003
572 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
573 TOXIC SKIN ERUPTION 3 0.0003
574 FULL BLOOD COUNT DECREASED 6 0.0003
575 BLOOD BILIRUBIN INCREASED 8 0.0003
576 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
577 LIVER DISORDER 13 0.0003
578 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
579 HAEMATURIA 10 0.0003
580 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
581 OSTEOPOROSIS 12 0.0003
582 APLASIA PURE RED CELL 1 0.0003
583 SKELETAL INJURY 3 0.0003
584 MULTI-ORGAN FAILURE 5 0.0003
585 AORTIC STENOSIS 1 0.0003
586 COUGH 80 0.0003
587 THERMAL BURN 2 0.0003
588 CARDIOGENIC SHOCK 4 0.0003
589 CONDITION AGGRAVATED 84 0.0003
590 DECREASED APPETITE 64 0.0003
591 LIVER FUNCTION TEST ABNORMAL 8 0.0003
592 FLUID OVERLOAD 4 0.0003
593 MELAENA 6 0.0003
594 AMYLASE INCREASED 1 0.0003
595 BLINDNESS 11 0.0003
596 BLOOD CALCIUM DECREASED 3 0.0003
597 HEPATIC CIRRHOSIS 5 0.0003
598 AUTOIMMUNE THYROIDITIS 1 0.0003
599 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
600 GASTRIC ULCER 5 0.0003
601 HEPATOCELLULAR CARCINOMA 2 0.0003
602 PROTEINURIA 5 0.0003
603 ATRIOVENTRICULAR BLOCK 2 0.0003
604 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
605 LUNG INFECTION 4 0.0003
606 PULMONARY HAEMORRHAGE 2 0.0003
607 OFF LABEL USE 223 0.0003
608 INFLAMMATION 13 0.0003
609 RENAL CYST 2 0.0003
610 RESPIRATORY TRACT CONGESTION 4 0.0003
611 OXYGEN SATURATION DECREASED 14 0.0002
612 HEPATITIS C 3 0.0002
613 TASTE DISORDER 5 0.0002
614 NO THERAPEUTIC RESPONSE 3 0.0002
615 SHOCK HAEMORRHAGIC 2 0.0002
616 INTENTIONAL DOSE OMISSION 7 0.0002
617 HYPERAESTHESIA 2 0.0002
618 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
619 PHARYNGITIS 3 0.0002
620 AORTIC DISSECTION 1 0.0002
621 HEMIPLEGIA 2 0.0002
622 BLOOD UREA INCREASED 4 0.0002
623 INTESTINAL OBSTRUCTION 9 0.0002
624 BRAIN OEDEMA 3 0.0002
625 CANDIDA INFECTION 4 0.0002
626 RENAL INJURY 7 0.0002
627 HYPOPHAGIA 6 0.0002
628 RESPIRATORY DISORDER 7 0.0002
629 PRURITUS GENERALISED 5 0.0002
630 RESPIRATORY TRACT INFECTION 6 0.0002
631 PLATELET COUNT INCREASED 3 0.0002
632 SPINAL OSTEOARTHRITIS 2 0.0002
633 CONVULSION 13 0.0002
634 LYMPHOCYTE COUNT DECREASED 4 0.0002
635 CARDIOTOXICITY 2 0.0002
636 QUALITY OF LIFE DECREASED 3 0.0002
637 MYALGIA 38 0.0002
638 GOUT 4 0.0002
639 DYSPHONIA 13 0.0002
640 HOSPITALISATION 34 0.0002
641 TOOTHACHE 4 0.0002
642 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
643 RETINAL DETACHMENT 2 0.0002
644 HYPOKALAEMIA 10 0.0002
645 PNEUMONIA 70 0.0002
646 NAUSEA 171 0.0002
647 HEPATIC STEATOSIS 4 0.0002
648 FLANK PAIN 2 0.0002
649 SKIN REACTION 3 0.0002
650 BLOOD SODIUM DECREASED 4 0.0002
651 CHRONIC KIDNEY DISEASE 16 0.0002
652 PULMONARY FIBROSIS 4 0.0002
653 ACCIDENTAL UNDERDOSE 3 0.0002
654 HYPOKINESIA 3 0.0002
655 EAR PAIN 4 0.0002
656 APATHY 3 0.0002
657 VITAMIN D DEFICIENCY 2 0.0002
658 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
659 DRUG INEFFECTIVE 268 0.0002
660 CARDIOMYOPATHY 3 0.0002
661 HOSPICE CARE 2 0.0002
662 VOMITING 95 0.0002
663 ADVERSE DRUG REACTION 18 0.0002
664 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
665 HYPOXIA 7 0.0002
666 ABDOMINAL PAIN 46 0.0002
667 BODY TEMPERATURE INCREASED 4 0.0002
668 CHEST DISCOMFORT 20 0.0002
669 HYPONATRAEMIA 11 0.0002
670 EYE PAIN 11 0.0002
671 RIB FRACTURE 4 0.0002
672 MUSCULOSKELETAL CHEST PAIN 3 0.0002
673 DIPLOPIA 5 0.0002
674 BONE DENSITY DECREASED 6 0.0002
675 BRAIN FOG 3 0.0002
676 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
677 DEPRESSED MOOD 10 0.0002
678 RENAL PAIN 2 0.0002
679 DYSGEUSIA 14 0.0002
680 CHILLS 22 0.0002
681 RETCHING 4 0.0002
682 HALLUCINATION 14 0.0002
683 ANAL ABSCESS 1 0.0002
684 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
685 MANIA 3 0.0002
686 INFLUENZA LIKE ILLNESS 15 0.0002
687 ASTHENOPIA 1 0.0002
688 VENTRICULAR TACHYCARDIA 3 0.0002
689 FEELING COLD 5 0.0002
690 SEPSIS 20 0.0002
691 MITRAL VALVE INCOMPETENCE 2 0.0002
692 PRODUCT AVAILABILITY ISSUE 4 0.0002
693 GASTRIC DISORDER 6 0.0002
694 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
695 PERICARDIAL EFFUSION 4 0.0002
696 ELECTROLYTE IMBALANCE 2 0.0002
697 RASH 75 0.0002
698 CARDIAC ARREST 14 0.0002
699 BLOOD IRON DECREASED 2 0.0002
700 CHOLECYSTITIS 2 0.0002
701 RHABDOMYOLYSIS 7 0.0002
702 DYSPNOEA 95 0.0002
703 CEREBRAL HAEMORRHAGE 6 0.0002
704 VISION BLURRED 23 0.0002
705 RASH PRURITIC 9 0.0002
706 BURSITIS 2 0.0002
707 BONE DISORDER 3 0.0002
708 ENCEPHALOPATHY 4 0.0002
709 SMALL INTESTINAL OBSTRUCTION 2 0.0002
710 ABDOMINAL DISCOMFORT 27 0.0002
711 AGEUSIA 4 0.0002
712 PLATELET COUNT DECREASED 17 0.0002
713 FOOT FRACTURE 3 0.0002
714 HYPOTHYROIDISM 5 0.0002
715 METABOLIC ACIDOSIS 5 0.0002
716 PULMONARY OEDEMA 7 0.0002
717 DIARRHOEA 100 0.0002
718 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
719 CHOKING 3 0.0002
720 BEDRIDDEN 2 0.0002
721 PULMONARY CONGESTION 2 0.0002
722 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
723 PANCREATITIS 8 0.0002
724 HAEMATOCRIT DECREASED 3 0.0002
725 VISUAL ACUITY REDUCED 5 0.0002
726 FEAR 4 0.0001
727 PRODUCT ADMINISTRATION ERROR 3 0.0001
728 ARRHYTHMIA 7 0.0001
729 TACHYPNOEA 2 0.0001
730 ABNORMAL LOSS OF WEIGHT 1 0.0001
731 ASTHENIA 55 0.0001
732 EXPOSURE DURING PREGNANCY 9 0.0001
733 ANAPHYLACTIC REACTION 8 0.0001
734 CARPAL TUNNEL SYNDROME 2 0.0001
735 IMPAIRED WORK ABILITY 3 0.0001
736 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
737 PARALYSIS 2 0.0001
738 SUBDURAL HAEMATOMA 2 0.0001
739 HYPOACUSIS 6 0.0001
740 RHINORRHOEA 9 0.0001
741 DRUG EFFECT INCOMPLETE 5 0.0001
742 C-REACTIVE PROTEIN INCREASED 5 0.0001
743 GASTROENTERITIS 2 0.0001
744 PULMONARY EMBOLISM 13 0.0001
745 PSYCHOTIC DISORDER 4 0.0001
746 TACHYCARDIA 12 0.0001
747 ORAL PAIN 3 0.0001
748 RASH PAPULAR 3 0.0001
749 SNEEZING 3 0.0001
750 THERAPEUTIC RESPONSE DECREASED 8 0.0001
751 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
752 AORTIC ANEURYSM 1 0.0001
753 DEVICE FAILURE 2 0.0001
754 SKIN DISCOLOURATION 6 0.0001
755 SHOCK 3 0.0001
756 VISUAL IMPAIRMENT 16 0.0001
757 DELUSION 2 0.0001
758 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
759 ACUTE MYELOID LEUKAEMIA 2 0.0001
760 THERAPY PARTIAL RESPONDER 2 0.0001
761 SLEEP DISORDER 9 0.0001
762 HAEMOGLOBIN DECREASED 13 0.0001
763 COMA 6 0.0001
764 SENSORY DISTURBANCE 2 0.0001
765 MUSCLE TIGHTNESS 2 0.0001
766 BACK DISORDER 2 0.0001
767 NEUTROPHIL COUNT DECREASED 5 0.0001
768 MULTIPLE FRACTURES 2 0.0001
769 LETHARGY 7 0.0001
770 MALAISE 53 0.0001
771 VIRAL INFECTION 4 0.0001
772 LIP SWELLING 4 0.0001
773 NASAL CONGESTION 7 0.0001
774 CELLULITIS 6 0.0001
775 FACE OEDEMA 2 0.0001
776 HYPERSENSITIVITY 22 0.0001
777 WHEEZING 7 0.0001
778 UNRESPONSIVE TO STIMULI 3 0.0001
779 SKIN ULCER 3 0.0001
780 ANXIETY 33 0.0001
781 RASH GENERALISED 3 0.0001
782 HAEMATOMA 3 0.0001
783 PRODUCT DOSE OMISSION ISSUE 34 0.0001
784 OEDEMA PERIPHERAL 14 0.0001
785 FATIGUE 89 0.0001
786 CHEST PAIN 21 0.0001
787 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
788 DEHYDRATION 15 0.0001
789 GALLBLADDER DISORDER 2 0.0001
790 DRUG EFFECT DECREASED 6 0.0001
791 ANAL INCONTINENCE 1 0.0001
792 FREQUENT BOWEL MOVEMENTS 3 0.0001
793 LIMB INJURY 3 0.0001
794 RESTLESS LEGS SYNDROME 2 0.0001
795 PANIC ATTACK 4 0.0001
796 DYSURIA 4 0.0001
797 ILLNESS 11 0.0001
798 PRURITUS 41 0.0001
799 ABORTION INDUCED 1 0.0001
800 COLITIS 4 0.0001
801 CONFUSIONAL STATE 17 0.0001
802 RED BLOOD CELL COUNT DECREASED 3 0.0001
803 HYPERSOMNIA 3 0.0001
804 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
805 ATELECTASIS 1 0.0001
806 HERNIA 2 0.0001
807 INTERSTITIAL LUNG DISEASE 5 0.0001
808 MYOCARDIAL INFARCTION 18 0.0001
809 URTICARIA 17 0.0001
810 HEPATIC FAILURE 3 0.0001
811 EMOTIONAL DISTRESS 12 0.0001
812 CORONARY ARTERY DISEASE 3 0.0001
813 FEEDING DISORDER 2 0.0001
814 DYSKINESIA 4 0.0001
815 DISCOMFORT 6 0.0001
816 ADVERSE EVENT 9 0.0001
817 PRODUCT PREPARATION ERROR 2 0.0001
818 ARTHRALGIA 40 0.0001
819 MEMORY IMPAIRMENT 13 0.0001
820 BRADYCARDIA 5 0.0001
821 HEADACHE 59 0.0001
822 EATING DISORDER 2 0.0001
823 POOR QUALITY SLEEP 2 0.0001
824 LACTIC ACIDOSIS 3 0.0001
825 UNEVALUABLE EVENT 7 0.0001
826 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
827 FAECES DISCOLOURED 2 0.0001
828 MENTAL DISORDER 4 0.0001
829 DYSPEPSIA 9 0.0001
830 ASPIRATION 1 0.0001
831 FEBRILE NEUTROPENIA 6 0.0001
832 FUNGAL INFECTION 3 0.0001
833 URINARY RETENTION 3 0.0001
834 INFECTION 13 0.0001
835 HYPERTENSION 19 0.0001
836 EYE PRURITUS 3 0.0001
837 THROAT IRRITATION 4 0.0001
838 ARTHRITIS 7 0.0001
839 CARDIAC FAILURE 7 0.0001
840 HERPES ZOSTER 5 0.0001
841 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
842 BONE PAIN 5 0.0001
843 WEIGHT INCREASED 19 0.0001
844 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
845 ATAXIA 1 0.0001
846 CATARACT 5 0.0001
847 DEPRESSION 19 0.0001
848 BLOOD PRESSURE FLUCTUATION 2 0.0001
849 STOMATITIS 5 0.0001
850 NEURALGIA 2 0.0001
851 ACCIDENTAL OVERDOSE 3 0.0001
852 RESTLESSNESS 3 0.0001
853 CEREBRAL INFARCTION 2 0.0001
854 PNEUMONIA ASPIRATION 2 0.0001
855 HYPOTENSION 16 0.0001
856 CARDIOVASCULAR DISORDER 2 0.0001
857 ABDOMINAL PAIN UPPER 16 0.0001
858 BACK PAIN 18 0.0001
859 DIZZINESS 38 0.0001
860 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
861 OROPHARYNGEAL PAIN 7 0.0001
862 THROMBOSIS 6 0.0001
863 THROAT TIGHTNESS 2 0.0001
864 OEDEMA 4 0.0001
865 DYSPHAGIA 7 0.0001
866 RESPIRATORY ARREST 2 0.0001
867 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
868 ANGINA PECTORIS 2 0.0001
869 SEIZURE 8 0.0001
870 DEVICE LEAKAGE 3 0.0001
871 PRODUCT USE ISSUE 13 0.0001
872 ANOSMIA 1 0.0001
873 ACUTE MYOCARDIAL INFARCTION 2 0.0001
874 LABORATORY TEST ABNORMAL 2 0.0001
875 COLITIS ULCERATIVE 3 0.0001
876 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
877 BLOOD POTASSIUM DECREASED 2 0.0001
878 COGNITIVE DISORDER 3 0.0001
879 BASAL CELL CARCINOMA 1 0.0001
880 INSOMNIA 17 0.0001
881 HEAD INJURY 2 0.0001
882 MULTIPLE SCLEROSIS 3 0.0001
883 GAIT DISTURBANCE 12 0.0001
884 LOSS OF CONSCIOUSNESS 8 0.0001
885 MOVEMENT DISORDER 2 0.0001
886 HYPOGLYCAEMIA 3 0.0001
887 DRY MOUTH 5 0.0001
888 ATRIAL FIBRILLATION 6 0.0001
889 DEEP VEIN THROMBOSIS 4 0.0001
890 OSTEONECROSIS 2 0.0001
891 SKIN DISORDER 2 0.0001
892 SOMNOLENCE 12 0.0001
893 SKIN EXFOLIATION 5 0.0001
894 SINUSITIS 6 0.0001
895 FEELING ABNORMAL 14 0.0001
896 JOINT SWELLING 7 0.0001
897 NIGHTMARE 2 0.0001
898 MUSCULOSKELETAL PAIN 3 0.0001
899 PARAESTHESIA 9 0.0001
900 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
901 DEVICE ISSUE 5 0.0001
902 CONSTIPATION 12 0.0001
903 HYPERGLYCAEMIA 2 0.0001
904 HAEMATOCHEZIA 3 0.0001
905 PAIN 33 0.0001
906 EPISTAXIS 4 0.0001
907 HYPOAESTHESIA 8 0.0001
908 BLISTER 3 0.0001
909 ASTHMA 6 0.0001
910 HOT FLUSH 4 0.0001
911 DIABETES MELLITUS 4 0.0001
912 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
913 PERIPHERAL SWELLING 8 0.0001
914 PLASMA CELL MYELOMA 2 0.0001
915 SURGERY 3 0.0001
916 DISORIENTATION 2 0.0001
917 ABORTION SPONTANEOUS 2 0.0000
918 IRRITABILITY 3 0.0000
919 ILL-DEFINED DISORDER 3 0.0000
920 DEVICE BREAKAGE 2 0.0000
921 VERTIGO 3 0.0000
922 LUNG NEOPLASM MALIGNANT 2 0.0000
923 CARDIO-RESPIRATORY ARREST 2 0.0000
924 OSTEOARTHRITIS 2 0.0000
925 ANGIOEDEMA 2 0.0000
926 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
927 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
928 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
929 SKIN IRRITATION 2 0.0000
930 RENAL DISORDER 2 0.0000
931 BLOOD CHOLESTEROL INCREASED 2 0.0000
932 PALPITATIONS 5 0.0000
933 OCULAR HYPERAEMIA 2 0.0000
934 RASH ERYTHEMATOUS 2 0.0000
935 MOBILITY DECREASED 3 0.0000
936 AGITATION 3 0.0000
937 ALOPECIA 8 0.0000
938 HEART RATE INCREASED 4 0.0000
939 DRY EYE 2 0.0000
940 SYNCOPE 4 0.0000
941 FLUSHING 4 0.0000
942 DRUG DOSE OMISSION BY DEVICE 3 0.0000
943 NERVOUSNESS 2 0.0000
944 DRY SKIN 5 0.0000
945 DEATH 32 0.0000
946 TREMOR 6 0.0000
947 MEDICATION ERROR 2 0.0000
948 NECK PAIN 2 0.0000
949 FLATULENCE 2 0.0000
950 RHEUMATOID ARTHRITIS 4 0.0000
951 EYE IRRITATION 2 0.0000
952 BALANCE DISORDER 3 0.0000
953 MUSCULOSKELETAL STIFFNESS 3 0.0000
954 ERYTHEMA 7 0.0000
955 FALL 11 0.0000
956 FEELING HOT 2 0.0000
957 NASOPHARYNGITIS 6 0.0000
958 CARDIAC DISORDER 3 0.0000
959 SWELLING 3 0.0000
960 HYPERHIDROSIS 4 0.0000
961 SWELLING FACE 2 0.0000
962 PAIN IN EXTREMITY 9 0.0000
963 ABDOMINAL DISTENSION 3 0.0000
964 HAEMORRHAGE 3 0.0000
965 BURNING SENSATION 2 0.0000
966 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
967 SKIN BURNING SENSATION 2 0.0000
968 OVERDOSE 6 0.0000
969 UNDERDOSE 2 0.0000
970 BRONCHITIS 2 0.0000
971 MUSCULAR WEAKNESS 3 0.0000
972 INCORRECT DOSE ADMINISTERED 6 0.0000
973 CARDIAC FAILURE CONGESTIVE 2 0.0000
974 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
975 CEREBROVASCULAR ACCIDENT 4 0.0000
976 URINARY TRACT INFECTION 4 0.0000
977 PRODUCT STORAGE ERROR 2 0.0000
978 INTENTIONAL PRODUCT MISUSE 2 0.0000
979 COVID-19 4 0.0000
980 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
981 CONTUSION 2 0.0000
982 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
983 ARTHROPATHY 1 0.0000
984 INFLUENZA 2 0.0000
985 MUSCLE SPASMS 3 0.0000
986 AMNESIA 1 0.0000
987 PSORIASIS 2 0.0000
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
989 PRODUCT QUALITY ISSUE 2 0.0000
990 BLOOD PRESSURE INCREASED 2 0.0000
991 INJECTION SITE PAIN 4 0.0000
992 NO ADVERSE EVENT 2 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000